In a recent study, a VDAC1‐interacting molecule, VBIT‐4, was successfully employed to mitigate neuronal cell death and inflammation that depend on Aβ‐induced overexpression of VDAC1 in a transgenic mice model of AD (Verma et al. 2022). This evidence concerns the gene VDAC1 and Alzheimer disease.